0RB1.LSE Laboratorio Reig Jofre S.A.

Healthcare Commercial Services & Supplies London Exchange
- EUR
Market cap
-
P/E
39.5x
P/B
-
ROE
-
Dividend yield
0.71%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2022.

Is 0RB1.LSE undervalued?

Graham number

The Graham number of Laboratorio Reig Jofre S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Laboratorio Reig Jofre S.A. fundamental analysis

No fundamental analysis for Laboratorio Reig Jofre S.A. yet.

Laboratorio Reig Jofre S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Laboratorio Reig Jofre S.A.

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint …

Full company profile